TY  - JOUR
AU  - Llerena, Susana
AU  - Cabezas, Joaquín
AU  - Cuadrado, Antonio
AU  - Manuel Olmos, José
AU  - González, Marta
AU  - García, Federico
AU  - Cobo, Carmen
AU  - Crespo, Javier
PY  - 2019
DO  - 10.5604/01.3001.0012.7931
SN  - 1665-2681
UR  - http://hdl.handle.net/10668/13999
T2  - Annals of hepatology
AB  - Nowadays, the retreatment of patients with Hepatitis C virus (HCV) genotype 3 (GT3) especially cirrhotic, who have already been treated with regimens containing a NS5A inhibitor represents a challenge. Use a novel retreatment option for patients with...
LA  - en
KW  - Genotype 3
KW  - Grazoprevir + Elbasvir
KW  - Hepatitis C virus
KW  - Sofosbuvir
KW  - Treatment failure
KW  - Amides
KW  - Antiviral Agents
KW  - Benzofurans
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle Aged
KW  - Quinoxalines
KW  - RNA, Viral
KW  - Retreatment
KW  - Sofosbuvir
KW  - Sulfonamides
KW  - Treatment Failure
TI  - Rescue Therapy for Genotype-3 DAA Non-responders, Almost all Done.
TY  - research article
VL  - 18
ER  -